Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris

NCT01498874 is registered in ClinicalTrials.gov with XOMA (US) LLC as lead sponsor.

NCT NCT01498874
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01498874 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Lead sponsor
XOMA (US) LLC
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2011
Completion date
June 30, 2013
Enrollment
127 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

acne vulgaris